CA3022332C - Forme polymorphe de n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulfonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide - Google Patents

Forme polymorphe de n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulfonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide

Info

Publication number
CA3022332C
CA3022332C CA3022332A CA3022332A CA3022332C CA 3022332 C CA3022332 C CA 3022332C CA 3022332 A CA3022332 A CA 3022332A CA 3022332 A CA3022332 A CA 3022332A CA 3022332 C CA3022332 C CA 3022332C
Authority
CA
Canada
Prior art keywords
disorders
compound
formula
polymorph
quoted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3022332A
Other languages
English (en)
Other versions
CA3022332A1 (fr
Inventor
Tobias THALER
Johannes Platzek
Nicolas GUIMOND
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Priority claimed from PCT/EP2017/059767 external-priority patent/WO2017186703A1/fr
Publication of CA3022332A1 publication Critical patent/CA3022332A1/fr
Application granted granted Critical
Publication of CA3022332C publication Critical patent/CA3022332C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des formes cristallines de N-{6-(2-Hydroxypropan-2-yl)-2-[2-(méthylsulfonyl)éthyl]-2H-indazol-5-yl}-6-(trifluorométhyl)pyridine-2-carboxamide, lesquelles correspondent au composé de la formule (I) des procédés pour leur préparation, des compositions pharmaceutiques les comprenant et leur utilisation pour lutter contre certains troubles.
CA3022332A 2016-04-29 2017-04-25 Forme polymorphe de n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulfonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide Active CA3022332C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16167652.3 2016-04-29
EP16167652 2016-04-29
PCT/EP2017/059767 WO2017186703A1 (fr) 2016-04-29 2017-04-25 Forme polymorphe de n-{6-(2-hydroxypropan-2-yl)-2-[2-(méthylsulfonyl)éthyl]-2h-indazol-5-yl}-6-(trifluorométhyl)pyridine-2-carboxamide

Publications (2)

Publication Number Publication Date
CA3022332A1 CA3022332A1 (fr) 2017-11-02
CA3022332C true CA3022332C (fr) 2025-11-18

Family

ID=

Similar Documents

Publication Publication Date Title
EP3448848B1 (fr) Forme polymorphe de n-{6-(2-hydroxypropan-2-yl)-2-[2-(méthylsulfonyl)éthyl]-2h-indazol-5-yl}-6-(trifluorométhyl)pyridine-2-carboxamide
AU2017257208B2 (en) Crystalline forms of N-(2-(3-Hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl)-6-(trifluoromethyl)pyridine-2-carboxamide
CA3022332C (fr) Forme polymorphe de n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulfonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide
CA3022329C (fr) Formes cristallines de n-[2-(3-hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2h-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
HK40055856A (en) Polymorphic form
HK40045075A (en) Crystalline forms of a compound
NZ746526B2 (en) Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide
EA042116B1 (ru) Полиморфная форма n-{6-(2-гидроксипропан-2-ил)-2-[2-(метилсульфонил)этил]-2н-индазол-5-ил}-6-(трифторметил)пиридин-2-карбоксамида
BR122024003780A2 (pt) Forma polimórfica de n-{6-(2-hidróxipropan-2-il)-2-[2-(metilsulfonil)etil] -2h-indazol-5-il}-6-(trifluorome-til)piridina-2-carboxamida
BR112018072242B1 (pt) Forma polimórfica de n-{6-(2-hidróxipropan-2-il)-2-[2- (metilsulfonil)etil] -2h-indazol-5-il}-6-(trifluorometil)piridina2-carboxamida, seus usos, e composição farmacêutica
HK40000352B (zh) N-{ 6-( 2-羟基丙-2-基)-2-[ 2-(甲基磺酰基)乙基]-2h-吲唑-5-基}-6-(三氟甲基)吡啶-2-甲酰胺的多晶型物
HK40000352A (en) Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide